References
- Healthcare Hits 100. www.ipreo.com/blog/2014/12/10/healthcare-hits-100/.
- CytoSorbents Corporation begins NASDAQ trading today. http://02c390e.netsolhost.com/news157.htm.
- CytoSorbents submits IDE application to FDA for US CytoSorb® Cardiac Surgery Trial. http://02c390e.netsolhost.com/news158.htm.
- Asante Solutions, Inc. ; Form S-1 Registration Statement. www.sec.gov/Archives/edgar/data/1620983/000119312514448769/d795546ds1.htm#toc795546_9.
- FDA approves Dexcom software with artificial pancreas algorithm. www.dexcom.com/news/1766768139-fda-approves-dexcom-software-artificial-pancreas-algorithm.
- Oak Crest receives $20 million grant for HIV prevention research. http://oak-crest.org/oakcrest-news/oak-crest-receives-20-million-grant-for-hiv-prevention-research/.
- US Army adopts and deploys PROVODINE® from microdermis to fight Ebola. www.microdermis.com/content/pdfs/Ebola_press_release_vRTA.pdf.
- ORAMED closes $5 million investment from Guangxi Wuzhou Pharmaceutical Company. www.oramed.com/oramed-closes-5-million-investment-from-guangxi-wuzhou-pharmaceutical-company/.
- NuvOx Pharma receives exclusive license from University of Arkansas. www.prweb.com/releases/2014/12/prweb12363783.htm.
- Unilife signs long-term commercial supply agreement for use of Depot-ject™ delivery system with approved ocular injection drug. http://files.shareholder.com/downloads/ABEA-474G59/3891758849×0×797392/d94ba101-58f6-41f0-b56f-d2d06030408a/UNIS_News_2014_12_2_General_Announcements.pdf.
- Catalent and Valerion therapeutics collaborate to bring new treatments for orphan genetic disorders to market. www.catalent.com/index.php/news-events/news/Catalent-And-Valerion-Therapeutics-Collaborate-To-Bring-New-Treatments-For-Orphan-Genetic-Disorders-To-Market.
- Teva announces FDA Approval of QNASL® (Beclomethasone Dipropionate) Nasal Aerosol for treatment of children with seasonal and perennial allergic rhinitis. www.tevapharm.com/Media/News/Pages/2014/2001044.aspx?year=2014.
- Endo Pharmaceuticals and BioDelivery Sciences announce NDA submission for Buprenorphine HCl Buccal Film for the management of moderate to severe chronic pain. www.endo.com/news-events/press-releases.
- Endo Pharmaceuticals and BioDelivery Sciences announce NDA submission for Buprenorphine HCl Buccal Film for the management of moderate to severe chronic pain. www.endo.com/news-events/press-releases.
- Arrowhead files IND for RNAi Therapeutic ARC-520 to begin Phase 2b multiple-dose studies in chronic hepatitis B patients. http://ir.arrowheadresearch.com/releasedetail.cfm?ReleaseID=887586.
- Medtronic completes global user evaluations for new insulin pump platform. http://newsroom.medtronic.com/phoenix.zhtml?c=251324&p=irol-newsArticle&ID=2001127.
- Insys Therapeutics receives FDA Orphan Drug Designation for liposome entrapped paclitaxel as a potential treatment for gastric cancer. www.insysrx.com/investors/recent-news/.
- Cerulean announces first patient dosed with CRLX301 in Phase 1/2a Trial in advanced solid tumors. http://ir.ceruleanrx.com/releasedetail.cfm?ReleaseID=888077.
- Marina Biotech reports that Licensee ProNAi Therapeutics presented interim Phase 2 data on its BCL2-targeting DNAi® Therapeutic at ASH 2014. www.marinabio.com/files/7814/1814/7113/14-12-09_-_Marina_Biotech_Reports_ProNAi_Therapeutics_Interim_Phase_2_Data.pdf.
- mPhase Smart Drug Delivery System Patent Update. www.businesswire.com/news/home/20141114005952/en/mPhase-Smart-Drug-Delivery-System-Patent-Update#.VMblVf7F-4I.
- MatSE researchers develop inexpensive hydrolyzable polymer. http://engineering.illinois.edu/news/article/10146.
- Injectable 3D vaccines could fight cancer and infectious diseases. http://wyss.harvard.edu/viewpressrelease/183.
- Kim J Li WA Choi Y et al. Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy. Nat. Biotechnol.33 (1), 64–72 (2015).
- Microchips Biotech, Inc. completes development and clinical demonstration of proprietary drug delivery platform and advances commercialization efforts in diabetes, contraception and osteoporosis. http://microchipsbiotech.com/news-pr-121514.php.
- Joachim EK Kim ID Jin Y Kim K Lee JK Choi H . Gelatin nanoparticles enhance the neuroprotective effects on intranasally administered osteopntin in rat ischemic stroke model. Drug Deliv. Transl. Res.4, 395–399 (2014).